FDA Import Refusal 1FX-2145552-3/10002/1 — SBL Private Limited
The FDA refused shipment 1FX-2145552-3/10002/1 from SBL Private Limited (India) on Sep 14, 2026. The refused product falls under Drugs and Biologics — MISCELLANEOUS PATENT MEDICINES, ETC.. Cited charges: 118,3280,75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Sep 14, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 66VDY99 MISCELLANEOUS PATENT MEDICINES, ETC.
- Charges
- 118,3280,75